Skip to main content
. 2021 Dec 13;326(24):1–10. doi: 10.1001/jama.2021.21892

Table 1. Baseline Characteristics.

Minimally invasive surfactant therapy
(n = 241)a
Control treatment
(n = 244)a
Demographic characteristics
Gestational age, median (IQR), wk 27.3 (26.3-28.1) 27.3 (26.4-28.0)
Birth weight
Mean (SD), g 929 (221) 928 (216)
<10th Percentile 34 (14.1) 34 (13.9)
Sex
Female 116 (48.1) 125 (51.2)
Male 125 (51.9) 119 (48.8)
Plurality and birth order
Singleton 150 (62.2) 169 (69.3)
First of multiples 41 (17.0) 32 (13.1)
Second or subsequent multiple 50 (20.7) 43 (17.6)
Peripartum details
Exposure to antenatal glucocorticoids, doses prior to delivery
≥2 156 (64.7) 175 (71.7)
1 63 (26.1) 50 (20.5)
0 22 (9.1) 19 (7.8)
Delivery mode
Vaginal 45 (18.7) 52 (21.3)
Cesarean with labor 96 (39.8) 82 (33.6)
Cesarean without labor 100 (41.5) 110 (45.1)
Apgar score at 5 min, median (IQR)b 8 (7-9) 8 (7-9)
Clinical state at randomization
Age, mean (SD), h 2.9 (1.4) 2.8 (1.5)
Continuous positive airway pressure level required at randomization, median (IQR), cm H2O 7 (6-8) 7 (6-8)
Fraction of inspired oxygen
Level required at randomization, median (IQR) 0.35 (0.30-0.39) 0.35 (0.30-0.40)
Level required ≤0.35 152 (63.1) 150 (61.5)
a

Data are expressed as No. (%) unless otherwise indicated.

b

Indicates success of transition at birth. The score range is 0 to 10. A score of 0 to 2 is given for each of the following: heart rate, respiratory effect, reflex irritability, muscle tone, and skin color. An Apgar score greater than 7 at 5 minutes after birth generally indicates a satisfactory transition for a preterm infant.